Click here to view the Humana Medical Policy Updates Updates » September 2024 Humana Medical…
Premera Blue Cross Medical Policy Updates – December 2018
Click here to view the Premera Blue Cross Medical Policy Updates »
December 2018 Medical Policy Updates:
- Adoptive Immunotherapy
- Amniotic Membrane and Amniotic Fluid
- Bone Mineral Density Studies
- Cialis® (tadalafil) for Benign Prostatic Hyperplasia
- Dynamic Spinal Visualization and Vertebral Motion Analysis
- Erythropoiesis-Stimulating Agents
- Facet Joint Denervation
- Focal Treatments for Prostate Cancer
- Genetic Cancer Susceptibility Panels Using Next – Generation Sequencing
- Genetic Testing for Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies
- Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes
- Growth Hormone Therapy
- Hepatitis C Antiviral Therapy
- Hetlioz® (tasimelteon)
- Increlex® (mecasermin); Recombinant Human Insulin-Like Growth Factor-1
- Keratoprosthesis
- Magnetic Esophageal Sphincter Augmentation to Treat Gastroesophageal Reflux Disease
- Medical Necessity Criteria for Pharmacy Ed
- Microarray-Based Gene Expression Profile Testing for Multiple Myeloma Risk Stratification
- Microwave Tumor Ablation
- Molecular Testing for the Management of Pancreatic Cysts, Barrett Esophagus, and Solid Pancreaticobiliary Lesions
- Monoclonal Antibodies for the Treatment of Lymphoma
- Myocardial Sympathetic Innervation Imaging in Patients with Heart Failure
- Pharmacogenetic Testing for Pain Management
- Pharmacotherapy of Cushing’s Disease and Acromegaly
- Prolotherapy
- Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Inhibitors
- Radiofrequency Ablation of Miscellaneous Solid Tumors Excluding Liver Tumors
- Radiofrequency Ablation of the Renal Sympathetic Nerves as a Treatment for Resistant Hypertension
- Repository Corticotropin Injection
- Rhinoplasty and Septoplasty Surgery
- Transcranial Magnetic Stimulation as a Treatment of Depression and Other Psychiatric/Neurologic Disorders
- Use of Common Genetic Variants (Single Nucleotide Variants) to Predict Risk of Non-familial Breast Cancer
- Whole Exome and Whole Genome Sequencing for Diagnosis of Genetic Disorders
Click here to view the Premera Blue Cross Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
